Ocan, Moses
Nakalembe, Loyce
Otike, Caroline
Mordecai, Tayebwa
Birungi, Joan
Nsobya, Sam
Funding for this research was provided by:
European and Developing Countries Clinical Trials Partnership (TMA2019CDF-2662 Pfkelch13 emergence)
Article History
Received: 13 February 2024
Accepted: 19 April 2024
First Online: 30 April 2024
Declarations
:
: The study protocol was reviewed and approved by Makerere University School of Biomedical Sciences Research Ethics Committee (SBS 803). The protocol was further reviewed and cleared by Uganda National Council of Science and Technology (UNCST), (HS1169ES). Administrative clearance was also obtained from the local authorities in the study settings. A written informed consent was obtained from drug outlet clients prior to data collection.
: Not applicable.
: The authors declare that they have no competing interests.